Table 1 Socio-demographic and clinical characteristics of study sample
Characteristics | UK Sample (N=144) | US sample (N=137) | |
|---|---|---|---|
Mean (STD) or N (%) | p* | ||
CKD stage | <0.01 | ||
CKD stage 1-2 | 24 (16.8) | 51 (37.5) | |
CKD stage 3 | 65 (45.5) | 50 (36.8) | |
CKD stage 4 | 37 (25.9) | 26 ( 19.1) | |
CKD stage 5 | 17 * (11.9) | 9 (6.6) | |
Women | 56 (39.2) | 46 (33.3) | 0.35 |
Age | 52.0 (13.8) | 49.1 (12.9) | 0.07 |
Months since Transplant | 63.7 (40.9) | 39.5 (52.8) | <0.01 |
Diabetes | 26 (18.2) | 46 (33.3) | <0.01 |
Cardiovascular Disease (CVD) | 44 (30.1) | 31 (22.6) | 0.13 |
Hypertension (HTN) | 82 (57.3) | 40 (29.2) | <0.01 |
Depression/Anxiety | 5 (3.5) | 15 (11.0) | 0.01 |
Albumin | 4.1 (0.3) | 4.0 (0.4) | 0.02 |
Hemoglobin | 12.9 (1.6) | 12.0 (2.0) | <0.01 |
Calcium | 9.8 (0.5) | 9.2 (0.9) | <0.01 |
Phosphorus | 3.3 (1.1) | 3.1 (0.8) | 0.08 |